Insider Trading & Ownership - Fenton Mary Kay

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Fenton Mary Kay

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-04-29
Option Award
2024-04-30
9:02 pm
N/A
2034-04-29
Cullinan Therapeutics Inc.CGEMFenton Mary Kay
Chief Financial Officer
200,000$0200,000
(Direct)
View
2023-07-03
Tax Withholding
2023-07-06
5:20 pm
N/A
N/A
Talaris Therapeutics Inc.TALSFenton Mary Kay
Chief Financial Officer
12,946$3.0868,054
(Direct)
View
2023-02-01
Option Award
2023-02-03
4:57 pm
N/A
2033-02-01
Talaris Therapeutics Inc.TALSFenton Mary Kay
Chief Financial Officer
300,000$0300,000
(Direct)
View
2022-09-10
Option Award
2022-09-13
4:29 pm
N/A
N/A
Talaris Therapeutics Inc.TALSFenton Mary Kay
Chief Financial Officer
80,000$081,000
(Direct)
View
2022-06-23
Option Award
2022-06-24
06:44 am
N/A
2032-06-23
Oncorus Inc.ONCRFenton Mary Kay
Director
12,500$012,500
(Direct)
View
2021-12-31
Option Award
2022-02-02
6:00 pm
N/A
N/A
Talaris Therapeutics Inc.TALSFenton Mary Kay
Chief Financial Officer
1,000$13201,000
(Direct)
View
2022-02-01
Option Award
2022-02-02
6:00 pm
N/A
2032-01-31
Talaris Therapeutics Inc.TALSFenton Mary Kay
Chief Financial Officer
200,000$0201,000
(Direct)
View
2021-06-16
Option Award
2021-06-17
5:57 pm
N/A
2031-06-15
Oncorus Inc.ONCRFenton Mary Kay
Director
12,500$012,500
(Direct)
View

Ownership
2021-05-06
9:14 pm
N/A
2031-02-21
Talaris Therapeutics Inc.TALSFenton Mary Kay
Chief Financial Officer
0$0364,485
(Direct)
View

Ownership
2020-10-01
7:04 pm
N/A
2029-12-18
Oncorus Inc.ONCRFenton Mary Kay
Director
0$09,927
(Direct)
View